Royalty Pharma plc Class A Ordinary Shares vs Valley National Bancorp Common Stock — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B), while Valley National Bancorp Common Stock trades at $12.76 (market cap $6.90B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 3.7× Valley National Bancorp Common Stock's market cap, and Valley National Bancorp Common Stock pays the higher dividend (3.53%). Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Valley National Bancorp Common Stock for 0 Days on average.
| RPRX | VLY | |
|---|---|---|
Market Cap | $25.27B | $6.90B |
Volume | 3,671,183 | 8,032,586 |
Sector | Health | Financials |
52-Week High | $63.96 | $15.19 |
52-Week Low | $35.44 | $9.72 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $32.50B | $9.40B |
Dividend Yield | 1.66% | 3.53% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →Valley National Bancorp is a financial holding company whose main subsidiary is Valley National Bank. It provides commercial, retail, trust, and investment services across several U.S. states.
Read more on VLY →